These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7532894)

  • 21. Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial.
    Bernstein SH; Fay JP; Christiansen NP; Pinero L; Shah D; Stephan M; Herzig GP
    Clin Cancer Res; 1997 Sep; 3(9):1519-26. PubMed ID: 9815838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free medium.
    De Bruyn C; Delforge A; Bron D; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1994 Nov; 12(6):616-25. PubMed ID: 7533580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells.
    Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M
    J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hematologic effects of interleukin-1 beta, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor in tumor-bearing mice treated with fluorouracil.
    Moore MA; Stolfi RL; Martin DS
    J Natl Cancer Inst; 1990 Jun; 82(12):1031-7. PubMed ID: 1693405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro chronopharmacology of recombinant mouse IL-3, mouse GM-CSF, and human G-CSF on murine myeloid progenitor cells.
    Perpoint B; Le Bousse-Kerdilès C; Clay D; Smadja-Joffe F; Deprés-Brummer P; Laporte-simitsidis S; Jasmin C; Lévi F
    Exp Hematol; 1995 Apr; 23(4):362-8. PubMed ID: 7534715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cellular basis for enhancement interactions between stem cell factor and the colony stimulating factors.
    Metcalf D
    Stem Cells; 1993 Jul; 11 Suppl 2():1-11. PubMed ID: 7691313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW; Li F; Pettit GR; Grant S
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the efficacy of mast cell growth factor (c-kit ligand) in vitro as well as in vivo.
    Hintz-Obertreis P; Weinmann E; Seiler FR
    Behring Inst Mitt; 1991 Dec; (90):14-22. PubMed ID: 1724901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.
    Cairo MS; Plunkett JM; Schendel P; van de Ven C
    Exp Hematol; 1994 Oct; 22(11):1118-23. PubMed ID: 7523164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible role of stem cell factor as a serum factor: monoclonal anti-c-kit antibody abrogates interleukin-6-dependent colony growth in serum-containing culture.
    Shiohara M; Koike K; Kubo T; Amano Y; Takagi M; Muraoka K; Nakao J; Nakahata T; Komiyama A
    Exp Hematol; 1993 Jul; 21(7):907-12. PubMed ID: 7686504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mobilization of hematopoietic stem cells in peripheral blood by leukapheresis].
    Zingsem J; Serke S; Zeiler T; Zimmermann R; Schwella N; Weisbach V; Eckstein R
    Beitr Infusionsther; 1993; 31():111-7. PubMed ID: 7693238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic effects between GM-CSF and G-CSF or M-CSF on highly enriched human marrow progenitor cells.
    Bot FJ; van Eijk L; Schipper P; Backx B; Löwenberg B
    Leukemia; 1990 May; 4(5):325-8. PubMed ID: 1697008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
    Gazzola MV; Collins NH; Tafuri A; Keever CA
    Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
    Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
    Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony-stimulating factor (rHuM-CSF).
    Kovacs CJ; Harrell JP; Evans MJ; Abernathy RS; Roberts CJ; Johnke RM
    Stem Cells; 1994 Jan; 12(1):103-13. PubMed ID: 8142915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic effects of stem cell factor and interleukin 6 or interleukin 11 on the expansion of murine hematopoietic progenitors in liquid suspension culture.
    Ariyama Y; Misawa S; Sonoda Y
    Stem Cells; 1995 Jul; 13(4):404-13. PubMed ID: 7549899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.
    Lemoli RM; Rosti G; Visani G; Gherlinzoni F; Miggiano MC; Fortuna A; Zinzani P; Tura S
    J Clin Oncol; 1996 Nov; 14(11):3018-25. PubMed ID: 8918500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of differentiation of murine progenitor cells derived from blast cell colonies under serum-deprived conditions.
    Migliaccio G; Migliaccio AR; Kaushansky K; Adamson JW
    Exp Hematol; 1989 Feb; 17(2):110-5. PubMed ID: 2463929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indomethacin augments granulocyte-macrophage colony-stimulating factor-induced hematopoiesis following 5-FU treatment.
    O'Reilly M; Gamelli RL
    Exp Hematol; 1990 Oct; 18(9):974-8. PubMed ID: 2204540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.